Cartidin
Indicated to address joint cartilage degradation to relieve persistent arthritis pain and support mobility.
- Category
- Pain & Anti-inflammatories
- Active ingredient
- Diacerein
- Route
- Oral use
- Form
- Capsule
- Strengths
- 50mg
Prescription and consultation requirements for Cartidin vary by destination and are determined by the fulfilment partner.
Cartidin details
- Condition
- Osteoarthritis
- Alternative names
- diacerein
- Therapeutic class
- Interleukin-1 Inhibitor
- Pharmacological class
- Anthraquinone Derivative
- Known off-label uses
- rheumatoid arthritis
- Contraindications
- inflammatory bowel disease; severe hepatic impairment; intestinal obstruction
- Minor side effects
- diarrhoea; loose stools; nausea
- Moderate side effects
- dark urine; abdominal pain; pruritus
- Serious side effects
- severe hepatotoxicity, requires immediate medical attention
- Dosage forms
- Capsule
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sun Pharma
- Onset Time
- 2–4 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Antacids; Diuretics; Laxatives
- Age restrictions
- Approved for adults over fifteen years.
Patient summary
indicated to address joint cartilage degradation to relieve persistent arthritis pain and support mobility.
Mechanism of action
Inhibits interleukin-1, reducing synthesis of inflammatory enzymes and halting progressive deterioration of articular structures.
Pregnancy and breastfeeding
TGA Category B: Avoid during pregnancy as safety is unconfirmed. Breastfeeding: Avoid.